UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026579
Receipt number R000030520
Scientific Title Pharmacokinetics of mianserin suppository in Japanese elderly healthy volunteers -a pilot study
Date of disclosure of the study information 2017/03/16
Last modified on 2020/03/22 16:21:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Pharmacokinetics of mianserin suppository in Japanese elderly healthy volunteers -a pilot study

Acronym

Pharmacokinetics of mianserin suppository in healthy volunteers

Scientific Title

Pharmacokinetics of mianserin suppository in Japanese elderly healthy volunteers -a pilot study

Scientific Title:Acronym

Pharmacokinetics of mianserin suppository in healthy volunteers

Region

Japan


Condition

Condition

delirium

Classification by specialty

Psychiatry

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate the pharmacokinetics of a single rectal administration of mianserin 20 mg suppository in elderly healthy volunteers

Basic objectives2

PK,PD

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Pharmacokinetics parameters (area under the blood concentration time curve, maximum drug concentration, time of maximum drug concentration, half-life)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

A single dose of mianserin 30 mg suppository will be rectally administered
Blood sampling will be conducted 7 times (at pre, 0.5, 1, 2, 4, 6, 8, 10, 24, 36, 48 hours).

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit

76 years-old >

Gender

Male

Key inclusion criteria

Healthy volunteers enrolled this study must be agreement with the following criteria:
1. Age between 65 and 75
2. Male
3. Subjects are competent to consent, keep the rule of this study and are able to report self condition
4. Subjects who are judged eligible by the investigator in several series of medical check

Key exclusion criteria

1. Subjects who have inappropriate medical history (ex., drug abuse, alcoholism, any kind of heart, liver, kidney, lung, eye, blood diseases and digestive system disorder, etc.) or who are ingested medicines during this study.
2. Smoker.
3. Any drug allergy.
4. Subjects who are using excessive alcohol regularly (cannot keep abstinence for study period).
5. Participation in any clinical trial within the last 3 months.
6. Subjects who are inadequate for enrollment judged by the investigators.

Target sample size

3


Research contact person

Name of lead principal investigator

1st name Shuichi
Middle name
Last name Nawata

Organization

Showa University

Division name

School of Pharmacy

Zip code

142-8555

Address

1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555.

TEL

03-3784-8000

Email

nawa_shu@cmed.showa-u.ac.jp


Public contact

Name of contact person

1st name Shuchi
Middle name
Last name Nawata

Organization

Showa University

Division name

School of Pharmacy

Zip code

142-8555

Address

1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555.

TEL

03-3784-8000

Homepage URL


Email

nawa_shu@cmed.showa-u.ac.jp


Sponsor or person

Institute

Department of Hospital Pharmaceutics

Institute

Department

Personal name



Funding Source

Organization

Grants-in-Aid for Scientific Research

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Clinical Research Institute for Clinical Pharmacology and Therapeutics
Showa University Karasuyama Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

lnstitutional Review Board of ShowaUniversity Karasuyama Hospital

Address

6-11-11 Kitakarasuyama,Setagaya-ku,Tokyo,157-8577 Japan

Tel

03-3300-5231

Email

scri@ofc.showa-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

昭和大学附属烏山病院内 昭和大学臨床薬理研究所(東京都)


Other administrative information

Date of disclosure of the study information

2017 Year 03 Month 16 Day


Related information

URL releasing protocol

http://www.showa-u.ac.jp/SUHK/guide/irb/report.html

Publication of results

Published


Result

URL related to results and publications

http://www.jscpt.jp/journal/pdf/j50_2.pdf

Number of participants that the trial has enrolled

3

Results

The effects of 20mg mianserin suppositories were evaluated in three healthy older male adults. Mianserin concentration in blood was measured using gas chromatography-mass spectrometry. tmax was 14.7(8.1)h; Cmax was 7.0
(1.4)ng mL; AUC0-48 was 196.7(19.6)h ng/mL

Results date posted

2020 Year 03 Month 22 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

healthy older male adults

Participant flow

Open call for participants

Adverse events

no

Outcome measures

pharmacokinetics of mianserin suppositories

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 09 Month 12 Day

Date of IRB

2017 Year 04 Month 14 Day

Anticipated trial start date

2017 Year 02 Month 17 Day

Last follow-up date

2017 Year 03 Month 31 Day

Date of closure to data entry

2017 Year 03 Month 31 Day

Date trial data considered complete

2017 Year 03 Month 31 Day

Date analysis concluded

2017 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 03 Month 16 Day

Last modified on

2020 Year 03 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030520


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name